体内CAR-Tin vivo CAR-T

体内重编程T细胞

每条都摘自下方编号的来源原文;只写事实,不写预测或建议。

主要参与者

  • Starna是一家开发用于体内治疗的RNA药物的生物技术公司。1
    Pfizer Inc. (NYSE: PFE) today announced that it entered into an exclusive licensing agreement with Starna Therapeutics, a biotechnology company developing RNA medicines designed to enable in vivo therapeutics.

来源

  1. Pfizer · Pfizer Enters into Exclusive Licensing Agreement with Starna Therapeutics for Autoimmune Diseases | Pfizer · 2026-11-18